Number of the records: 1  

Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases

  1. 1.
    SYSNO ASEP0467409
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleDesign and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases
    Author(s) Břehová, Petra (UOCHB-X) RID, ORCID
    Šmídková, Markéta (UOCHB-X) RID, ORCID
    Skácel, Jan (UOCHB-X) ORCID, RID
    Dračínský, Martin (UOCHB-X) RID, ORCID
    Mertlíková-Kaiserová, Helena (UOCHB-X) RID, ORCID
    Velasquez, M. P. S. (US)
    Watts, V. J. (US)
    Janeba, Zlatko (UOCHB-X) RID, ORCID
    Source TitleChemMedChem. - : Wiley - ISSN 1860-7179
    Roč. 11, č. 22 (2016), s. 2534-2546
    Number of pages13 s.
    Languageeng - English
    CountryDE - Germany
    Keywordsadenylate cyclase toxin ; acyclic nucleoside phosphonates ; anthranilic acid
    Subject RIVCC - Organic Chemistry
    R&D ProjectsVG20102015046 GA MV - Ministry of Interior (MV)
    LO1302 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUOCHB-X - RVO:61388963
    UT WOS000388507100008
    EID SCOPUS84995953618
    DOI10.1002/cmdc.201600439
    AnnotationBordetella pertussis adenylate cyclase toxin (ACT) and Bacillus anthracis edema factor (EF) are key virulence factors with adenylate cyclase (AC) activity that substantially contribute to the pathogenesis of whooping cough and anthrax, respectively. There is an urgent need to develop potent and selective inhibitors of bacterial ACs with prospects for the development of potential antibacterial therapeutics and to study their molecular interactions with the target enzymes. Novel fluorescent 5-chloroanthraniloyl-substituted acyclic nucleoside phosphonates (Cl-ANT-ANPs) were designed and synthesized in the form of their diphosphates (Cl-ANT-ANPpp) as competitive ACT and EF inhibitors with sub-micromolar potency (IC50 values: 11-622nm). Fluorescence experiments indicated that Cl-ANT-ANPpp analogues bind to the ACT active site, and docking studies suggested that the Cl-ANT group interacts with Phe306 and Leu60. Interestingly, the increase in direct fluorescence with Cl-ANT-ANPpp having an ester linker was strictly calmodulin (CaM)-dependent, whereas Cl-ANT-ANPpp analogues with an amide linker, upon binding to ACT, increased the fluorescence even in the absence of CaM. Such a dependence of binding on structural modification could be exploited in the future design of potent inhibitors of bacterial ACs. Furthermore, one Cl-ANT-ANP in the form of a bisamidate prodrug was able to inhibit B.pertussis ACT activity in macrophage cells with IC50=12m.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Year of Publishing2017
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.